Overview

Update
IPO / Stock
Went Public on Oct 7, 2015 / NASDAQ:ACRS
Total Equity Funding
$82M in 3 Rounds from 9 Investors
Headquarters:
Malvern, PA
Description:
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Founders:
, , ,
Categories:
Pharmaceutical, Therapeutics, Biotechnology
Website:
http://www.aclaristx.com
Social:

Funding Rounds (4) - $102M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2016$20M / Post Ipo Equity0
Sep, 2015$40M / Series C8
Oct, 2014$21M / Series B3
Oct, 2012$21M / Series A3

Current Team (4)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    101 Lindenwood Drive

    Suite 400

    Malvern, PA 19355

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos